Aurobindo Pharma USA is in the midst of a major expansion to its U.S. footprint.

The most significant brick and mortar addition is the erecting of new 67.000 square foot facility in East Windsor, NJ. It will feature a state-of-the-art warehousing and distribution which will allow us to better serve the needs of our valued customer partners. The facility will also be the home for increased research and scientific study as well as more packaging lines. A second R&D site, this one in North Carolina was established in 2016. This site is under renovation; with this remodel project’s expansion to 140,000 square feet, Aurobindo’s commitment to scientific study has increased exponentially.